BerandaBSX • NYSE
add
Boston Scientific Corporation
$90,21
Sebelum Jam Perdagangan Normal:(0,86%)+0,78
$90,99
Tutup: 27 Nov, 00.09.45 GMT-5 · USD · NYSE · Pernyataan Penyangkalan
Tutup sebelumnya
$89,25
Rentang hari
$89,10 - $90,39
Rentang tahun
$53,93 - $91,93
Kapitalisasi pasar
134,07Â M USD
Volume Rata-Rata
6,92Â jt
Rasio P/E
74,57
Hasil dividen
-
Bursa utama
NYSE
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 4,21Â M | 19,34% |
Biaya operasional | 2,17Â M | 20,38% |
Laba bersih | 469,00Â jt | -7,13% |
Margin laba bersih | 11,14 | -22,21% |
Penghasilan per saham | 0,63 | 26,00% |
EBITDA | 1,02Â M | 12,65% |
Tarif pajak efektif | 29,90% | — |
Neraca
Total aset
Total liabilitas
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 2,50Â M | 162,82% |
Total aset | 38,08Â M | 11,85% |
Total liabilitas | 17,12Â M | 14,80% |
Total ekuitas | 20,96 M | — |
Saham yang beredar | 1,47 M | — |
Harga terhadap nilai buku | 6,35 | — |
Tingkat pengembalian aset | 4,77% | — |
Tingkat pengembalian modal | 5,63% | — |
Arus Kas
Perubahan kas bersih
(USD) | Sep 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 469,00Â jt | -7,13% |
Kas dari operasi | 1,00Â M | 43,55% |
Kas dari investasi | -1,43Â M | -624,37% |
Kas dari pembiayaan | 7,00Â jt | -56,25% |
Perubahan kas bersih | -412,00Â jt | -180,31% |
Arus kas bebas | 612,38Â jt | 43,29% |
Tentang
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts and incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator which they call the EMBLEM subcutaneous implantable defibrillator. Wikipedia
Didirikan
29 Jun 1979
Kantor pusat
Situs
Karyawan
48.000